Jupiter Topco LLC Acquires New Shares in CME Group Inc. $CME

by · The Markets Daily

Jupiter Topco LLC acquired a new position in CME Group Inc. (NASDAQ:CMEFree Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 1,791,092 shares of the financial services provider’s stock, valued at approximately $395,519,000.

A number of other hedge funds have also bought and sold shares of the business. Northwestern Mutual Investment Management Company LLC boosted its holdings in shares of CME Group by 0.3% during the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock valued at $3,147,000 after acquiring an additional 37 shares during the last quarter. Rehmann Capital Advisory Group grew its stake in shares of CME Group by 4.3% in the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock worth $243,000 after acquiring an additional 37 shares during the period. Endowment Wealth Management Inc. raised its holdings in shares of CME Group by 4.4% during the fourth quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider’s stock valued at $244,000 after purchasing an additional 38 shares during the last quarter. NBT Bank N A NY raised its holdings in shares of CME Group by 2.3% during the first quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider’s stock valued at $492,000 after purchasing an additional 38 shares during the last quarter. Finally, Resonant Capital Advisors LLC lifted its position in CME Group by 3.8% during the first quarter. Resonant Capital Advisors LLC now owns 1,073 shares of the financial services provider’s stock valued at $317,000 after purchasing an additional 39 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In other CME Group news, Director William R. Shepard acquired 325 shares of the business’s stock in a transaction dated Thursday, June 25th. The stock was purchased at an average price of $230.57 per share, with a total value of $74,935.25. Following the transaction, the director directly owned 260,442 shares in the company, valued at approximately $60,050,111.94. The trade was a 0.12% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.30% of the stock is owned by corporate insiders.

CME Group Price Performance

Shares of NASDAQ:CME opened at $277.32 on Wednesday. The firm’s 50 day moving average price is $251.75 and its 200-day moving average price is $279.35. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a market capitalization of $99.72 billion, a PE ratio of 23.52, a price-to-earnings-growth ratio of 3.32 and a beta of 0.23.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. The company had revenue of $1.71 billion for the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The firm’s revenue was up .8% compared to the same quarter last year. During the same quarter last year, the firm posted $2.96 earnings per share. Equities research analysts expect that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be paid a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 44.11%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. Barclays dropped their target price on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating on the stock in a report on Thursday, July 9th. Morgan Stanley boosted their target price on shares of CME Group from $324.00 to $330.00 and gave the company an “overweight” rating in a research note on Thursday, July 23rd. Weiss Ratings cut CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, August 11th. Keefe, Bruyette & Woods upgraded CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price target on the stock in a research note on Thursday, June 18th. Finally, JPMorgan Chase & Co. lifted their price objective on CME Group from $249.00 to $250.00 and gave the stock an “underweight” rating in a report on Thursday, July 23rd. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $288.56.

Check Out Our Latest Stock Report on CME

CME Group Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).